Immunotherapy for Post-COVID Neuropsychiatric Symptoms: The Potential of IVIG Treatment

Immunotherapy Post-COVID Neuropsychiatric symptoms IVIG treatment IVIG Autoimmune disorders Psychiatric disorders Neuroinflammation Immune system Intravenous immunoglobulin

Authors

  • Travis Satnarine
    travissatnarine@gmail.com
    Department of Neonatology, Port of Spain General Hospital, Trinidad and Tobago
  • Areeg Ahmed California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534
  • Ayesha Haq California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534
  • Deepkumar Patel California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534
  • Sai Dheeraj Gutlapalli California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534
  • Grethel N. Hernandez California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534
  • Kofi Seffah California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534
  • Mustafa Abrar Zaman California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534
  • Nimra Awais California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534
  • Safeera Khan California Institute of Behavioral Neurosciences & Psychology LLC, 4751 Mangels Blvd, Fairfield, CA 94534
April 3, 2023

Downloads

This paper explores the neuropsychiatric consequences of SARS-CoV-2 (COVID-19) infection, specifically the use of intravenous immunoglobulin (IVIG) therapy in treating central nervous system (CNS) symptoms associated with COVID-19. The authors searched PubMed and Google Scholar using the keywords "IVIG" and "covid-19 neuropsychiatric symptoms" to find five articles, including three case reports, a retrospective study, and a prospective study, that detail the experiences of individuals with persistent neuropsychiatric symptoms after contracting COVID-19. The neuropsychiatric symptoms reported in the analyzed studies include sleep disturbance, exhaustion, cognitive decline, anxiety, and others. Common treatments for post-COVID neuropsychiatric symptoms include medications, cognitive behavioral therapy, and lifestyle modifications. IVIG therapy to manage CNS symptoms of COVID-19 has shown mixed results in studies, with some showing positive effects while others remain inconclusive. Further research is needed to understand this therapy's potential benefits and limitations fully.

Most read articles by the same author(s)